Virta Health

Virta's nutrition intervention requires members to change food choices and sustain those habits while receiving clinical support.

Virta's cited diabetes outcome studies include open-label, non-randomized designs, which differ from blinded randomized comparisons.

Virta markets against a large disease burden, citing 109 million U.S. adults with obesity, 79 million overweight, and 38 million with type 2 diabetes, at 586 billion dollars in annual cost.

Rising GLP-1 adoption has intensified sponsor demand for interventions that control weight-loss drug spend; Virta integrates with ASO, commercial, and Medicare Advantage lines.

Virta's individual enrollment page lists uncovered access at $299 per month plus a $250 initiation fee, with an enrollment consultation offered at no charge. Fully covered employer or health-plan members can receive the program without out-of-pocket charges; clinical eligibility and coverage are checked during enrollment.

Employer and health-plan pricing depends on sponsor contracts, while Virta links commercial guarantees to clinical and financial results. Its buyer materials put fees at risk against blood-sugar improvement, weight loss, prescription reduction, and claims-based return on investment.